{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:46:58Z","timestamp":1760014018202},"reference-count":47,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,2]]},"DOI":"10.7759\/cureus.51521","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T14:35:09Z","timestamp":1704206109000},"source":"Crossref","is-referenced-by-count":3,"title":["Incidence and Risks of HIV Infection, Medication Options, and Adverse Effects in Accidental Needle Stick Injuries: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Raegan  B","family":"Abadie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise  M","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John  R","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan A","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha","family":"Allampalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahab","family":"Ahmadzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan D","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Needlestick","author":"King KC","year":"2023","unstructured":"King KC, Strony R. Needlestick. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-91814-5.00023-4","article-title":"Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat","author":"Sued O","year":"2023","unstructured":"Sued O, Grosso TM. Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat. Viral Infections and Antiviral Therapies. Dhara AK, Nayak AK (ed): Academic Press, London, UK; 2023. 339-76. 10.1016\/B978-0-323-91814-5.00023-4"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/v14020404","article-title":"HIV Infection and Spread between Th(17) Cells","volume":"14","author":"Zayas JP","year":"2022","unstructured":"Zayas JP, Mamede JI. HIV Infection and Spread between Th(17) Cells. Viruses. 2022, 14:404. 10.3390\/v14020404","journal-title":"Viruses"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-021-00566-0","article-title":"The HIV-1 capsid and reverse transcription","volume":"18","author":"Aiken C","year":"2021","unstructured":"Aiken C, Rousso I. The HIV-1 capsid and reverse transcription. Retrovirology. 2021, 18:29. 10.1186\/s12977-021-00566-0","journal-title":"Retrovirology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S104942","article-title":"Occupational HIV risk for health care workers: risk factor and the risk of infection in the course of professional activities","volume":"12","author":"Wy\u017cgowski P","year":"2016","unstructured":"Wy\u017cgowski P, Rosiek A, Grzela T, Leksowski K. Occupational HIV risk for health care workers: risk factor and the risk of infection in the course of professional activities. Ther Clin Risk Manag. 2016, 12:989-94. 10.2147\/TCRM.S104942","journal-title":"Ther Clin Risk Manag"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.15171\/ijhpm.2019.91","article-title":"HIV modes of transmission in Sudan in 2014","volume":"9","author":"Nasirian M","year":"2020","unstructured":"Nasirian M, Kianersi S, Karamouzian M, Sidahmed M, Baneshi MR, Haghdoost AA, Sharifi H. HIV modes of transmission in Sudan in 2014. Int J Health Policy Manag. 2020, 9:108-15. 10.15171\/ijhpm.2019.91","journal-title":"Int J Health Policy Manag"},{"key":"ref7","unstructured":"Occupational HIV Transmission and\r\nPrevention among Health Care Workers. (2019). Accessed. December 28, 2023: https:\/\/www.cdc.gov\/hiv\/pdf\/workplace\/cdc-hiv-healthcareworkers.pdf."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000298","article-title":"Estimating per-act HIV transmission risk: a systematic review","volume":"28","author":"Patel P","year":"2014","unstructured":"Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk: a systematic review. AIDS. 2014, 28:1509-19. 10.1097\/QAD.0000000000000298","journal-title":"AIDS"},{"key":"ref9","unstructured":"Bloodborne Pathogens and Needlestick Prevention. Accessed. 12\/28\/2023: https:\/\/www.osha.gov\/bloodborne-pathogens\/evaluating-controlling-exposure."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-019-09868-9","article-title":"Beneficial and adverse effects of cART affect neurocognitive function in HIV-1 infection: balancing viral suppression against neuronal stress and injury","volume":"16","author":"Yuan NY","year":"2021","unstructured":"Yuan NY, Kaul M. Beneficial and adverse effects of cART affect neurocognitive function in HIV-1 infection: balancing viral suppression against neuronal stress and injury. J Neuroimmune Pharmacol. 2021, 16:90-112. 10.1007\/s11481-019-09868-9","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-021-00573-y","article-title":"Correction to: a review of interventions to enhance HIV medication adherence","volume":"18","author":"Whiteley LB","year":"2021","unstructured":"Whiteley LB, Olsen EM, Haubrick KK, Odoom E, Tarantino N, Brown LK. Correction to: a review of interventions to enhance HIV medication adherence. Curr HIV\/AIDS Rep. 2021, 18:458. 10.1007\/s11904-021-00573-y","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref12","unstructured":"FDA-Approved HIV Medicines. (2023). https.\/\/hivinfo.nih.gov\/understanding-hiv\/fact-sheets\/fda-approved-hiv-medicines."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01379-9","article-title":"HIV-1 integrase inhibitors: a comparative review of efficacy and safety","volume":"80","author":"Scarsi KK","year":"2020","unstructured":"Scarsi KK, Havens JP, Podany AT, Avedissian SN, Fletcher CV. HIV-1 integrase inhibitors: a comparative review of efficacy and safety. Drugs. 2020, 80:1649-76. 10.1007\/s40265-020-01379-9","journal-title":"Drugs"},{"key":"ref14","article-title":"Chinese guidelines for the diagnosis and treatment of HIV\/AIDS (2021 Edition)","volume":"2","year":"2022","unstructured":"Chinese guidelines for the diagnosis and treatment of HIV\/AIDS (2021 Edition). Infect Dis Immun. 2022, 2.145-67.","journal-title":"Infect Dis Immun"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.120201","article-title":"HIV biosensors for early diagnosis of infection: the intertwine of nanotechnology with sensing strategies","volume":"206","author":"Farzin L","year":"2020","unstructured":"Farzin L, Shamsipur M, Samandari L, Sheibani S. HIV biosensors for early diagnosis of infection: the intertwine of nanotechnology with sensing strategies. Talanta. 2020, 206:120201.","journal-title":"Talanta"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/jalm\/jfab069","article-title":"Real-world clinical performance evaluation of a fourth-generation HIV antigen\/antibody differentiation test","volume":"6","author":"Krasowski MD","year":"2021","unstructured":"Krasowski MD, Wier D, Smith S, Riedel A, Lauseker-Hao Y, Kelner M, Wang S. Real-world clinical performance evaluation of a fourth-generation HIV antigen\/antibody differentiation test. J Appl Lab Med. 2021, 6:1417-32. 10.1093\/jalm\/jfab069","journal-title":"J Appl Lab Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013207.pub2","article-title":"Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less","volume":"8","author":"Ochodo EA","year":"2021","unstructured":"Ochodo EA, Guleid F, Deeks JJ, Mallett S. Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less. Cochrane Database Syst Rev. 2021, 8:CD013207. 10.1002\/14651858.CD013207.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03030-20","article-title":"An HIV diagnostic testing algorithm using the cobas HIV-1\/HIV-2 qualitative assay for HIV type differentiation and confirmation","volume":"59","author":"Duncan D","year":"2021","unstructured":"Duncan D, Duncan J, Kramer B, et al..  An HIV diagnostic testing algorithm using the cobas HIV-1\/HIV-2 qualitative assay for HIV type differentiation and confirmation. J Clin Microbiol. 2021, 59:e0303020. 10.1128\/JCM.03030-20","journal-title":"J Clin Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/phn.12917","article-title":"HIV self-testing: a review and analysis to guide HIV prevention policy","volume":"38","author":"O'Byrne P","year":"2021","unstructured":"O'Byrne P. HIV self-testing: a review and analysis to guide HIV prevention policy. Public Health Nurs. 2021, 38:885-91. 10.1111\/phn.12917","journal-title":"Public Health Nurs"},{"key":"ref20","article-title":"OSHA bloodborne pathogen standards","author":"Denault D","year":"2023","unstructured":"Denault D, Gardner H. OSHA bloodborne pathogen standards. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000294","article-title":"Prevention of needle-stick injury among nurses in an acute ward of a hospital: a best practice implementation project","volume":"20","author":"Huang HM","year":"2022","unstructured":"Huang HM, Chien HC, Lin WL, Chang CH, Chang MY, Su JY, Mu PF. Prevention of needle-stick injury among nurses in an acute ward of a hospital: a best practice implementation project. JBI Evid Implement. 2022, 20:134-43. 10.1097\/XEB.0000000000000294","journal-title":"JBI Evid Implement"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2007.10.007","article-title":"2007 guideline for isolation precautions: Preventing transmission of infectious agents in health care settings","volume":"35","author":"Siegel JD","year":"2007","unstructured":"Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 guideline for isolation precautions: Preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007, 35:S65-164. 10.1016\/j.ajic.2007.10.007","journal-title":"Am J Infect Control"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2021.04.009","article-title":"Occupational health update: evaluation and management of exposures and postexposure prophylaxis","volume":"35","author":"Shenoy ES","year":"2021","unstructured":"Shenoy ES, Weber DJ. Occupational health update: evaluation and management of exposures and postexposure prophylaxis. Infect Dis Clin North Am. 2021, 35:735-54. 10.1016\/j.idc.2021.04.009","journal-title":"Infect Dis Clin North Am"},{"key":"ref24","article-title":"Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use","volume":"39","year":"1990","unstructured":"Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. MMWR Recomm Rep. 1990, 39.1-14.","journal-title":"MMWR Recomm Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1086\/672271","article-title":"Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis","volume":"34","author":"Kuhar DT","year":"2013","unstructured":"Kuhar DT, Henderson DK, Struble KA, et al.. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol. 2013, 34:875-92. 10.1086\/672271","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001138","article-title":"Rapid testing algorithm performance in a low-prevalence environment","volume":"47","author":"Martin EG","year":"2020","unstructured":"Martin EG, Cornett J, Mohammed DY, Salaru G. Rapid testing algorithm performance in a low-prevalence environment. Sex Transm Dis. 2020, 47:S35-40. 10.1097\/OLQ.0000000000001138","journal-title":"Sex Transm Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2011.09.011","article-title":"Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections","volume":"52 Suppl 1","author":"Masciotra S","year":"2011","unstructured":"Masciotra S, McDougal JS, Feldman J, Sprinkle P, Wesolowski L, Owen SM. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. J Clin Virol. 2011, 52 Suppl 1:S17-22. 10.1016\/j.jcv.2011.09.011","journal-title":"J Clin Virol"},{"key":"ref28","article-title":"Evaluation of the performance of the Abbott ARCHITECT HIV Ag\/Ab Combo Assay","volume":"52 Suppl 1","author":"Chavez P","year":"2011","unstructured":"Chavez P, Wesolowski L, Patel P, Delaney K, Owen SM. Evaluation of the performance of the Abbott ARCHITECT HIV Ag\/Ab Combo Assay. J Clin Virol. 2011, 52 Suppl 1:S51-5.","journal-title":"J Clin Virol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00715-23","article-title":"Towards novel HIV-1 serodiagnostic tests without vaccine-induced seroreactivity","volume":"11","author":"Lagatie O","year":"2023","unstructured":"Lagatie O, Lauwers D, Singh H, et al.. Towards novel HIV-1 serodiagnostic tests without vaccine-induced seroreactivity. Microbiol Spectr. 2023, 11:e0071523. 10.1128\/spectrum.00715-23","journal-title":"Microbiol Spectr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001124","article-title":"Performance of an alternative laboratory-based HIV diagnostic testing algorithm using HIV-1 RNA viral load","volume":"47","author":"Pitasi MA","year":"2020","unstructured":"Pitasi MA, Patel SN, Wesolowski LG, Masciotra S, Luo W, Owen SM, Delaney KP. Performance of an alternative laboratory-based HIV diagnostic testing algorithm using HIV-1 RNA viral load. Sex Transm Dis. 2020, 47:S18-25. 10.1097\/OLQ.0000000000001124","journal-title":"Sex Transm Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199711203372101","article-title":"A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group","volume":"337","author":"Cardo DM","year":"1997","unstructured":"Cardo DM, Culver DH, Ciesielski CA, et al.. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med. 1997, 337:1485-90. 10.1056\/NEJM199711203372101","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac130","article-title":"Efficacy and safety of switching to the 2-Drug regimen Dolutegravir\/Lamivudine versus continuing a 3- or 4-Drug regimen for maintaining virologic suppression in adults living with human immunodeficiency virus 1 (HIV-1): week 48 results from the phase 3, noninferiority SALSA randomized trial","volume":"76","author":"Llibre JM","year":"2023","unstructured":"Llibre JM, Brites C, Cheng CY, et al.. Efficacy and safety of switching to the 2-Drug regimen Dolutegravir\/Lamivudine versus continuing a 3- or 4-Drug regimen for maintaining virologic suppression in adults living with human immunodeficiency virus 1 (HIV-1): week 48 results from the phase 3, noninferiority SALSA randomized trial. Clin Infect Dis. 2023, 76:720-9. 10.1093\/cid\/ciac130","journal-title":"Clin Infect Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/v12060617","article-title":"Next-generation sequencing for HIV drug resistance testing: Laboratory, clinical, and implementation considerations","volume":"12","author":"\u00c1vila-R\u00edos S","year":"2020","unstructured":"\u00c1vila-R\u00edos S, Parkin N, Swanstrom R, Paredes R, Shafer R, Ji H, Kantor R.  Next-generation sequencing for HIV drug resistance testing: Laboratory, clinical, and implementation considerations. Viruses. 2020, 12:617. 10.3390\/v12060617","journal-title":"Viruses"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000588","article-title":"HIV treatment and prevention 2019: current standards of care","volume":"15","author":"Phanuphak N","year":"2020","unstructured":"Phanuphak N, Gulick RM. HIV treatment and prevention 2019: current standards of care. Curr Opin HIV AIDS. 2020, 15:4-12. 10.1097\/COH.0000000000000588","journal-title":"Curr Opin HIV AIDS"},{"key":"ref35","article-title":"HIV testing","author":"Huynh K","year":"2023","unstructured":"Huynh K, Kahwaji CI. HIV testing. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/life13041014","article-title":"HIV-indicator condition guided testing in a hospital setting","volume":"13","author":"Barbanotti D","year":"2023","unstructured":"Barbanotti D, Tincati C, Tavelli A, et al.. HIV-indicator condition guided testing in a hospital setting. Life (Basel). 2023, 13:1014. 10.3390\/life13041014","journal-title":"Life (Basel)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/DMP.0b013e318187ac66","article-title":"Postexposure interventions to prevent infection with HBV, HCV, or HIV, and tetanus in people wounded during bombings and other mass casualty events--United States, 2008: recommendations of the Centers for Disease Control and Prevention and Disaster Medicine and Public Health Preparedness","volume":"2","author":"Chapman LE","year":"2008","unstructured":"Chapman LE, Sullivent EE, Grohskopf LA, et al.. Postexposure interventions to prevent infection with HBV, HCV, or HIV, and tetanus in people wounded during bombings and other mass casualty events--United States, 2008: recommendations of the Centers for Disease Control and Prevention and Disaster Medicine and Public Health Preparedness. Disaster Med Public Health Prep. 2008, 2:150-65. 10.1097\/DMP.0b013e318187ac66","journal-title":"Disaster Med Public Health Prep"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000218543.46963.6d","article-title":"Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis","volume":"20","author":"Baggaley RF","year":"2006","unstructured":"Baggaley RF, Boily MC, White RG, Alary M. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS. 2006, 20:805-12. 10.1097\/01.aids.0000218543.46963.6d","journal-title":"AIDS"},{"key":"ref39","article-title":"Notes from the field: occupationally acquired HIV infection among health care workers - United States, 1985-2013","volume":"63","author":"Joyce MP","year":"2015","unstructured":"Joyce MP, Kuhar D, Brooks JT. Notes from the field: occupationally acquired HIV infection among health care workers - United States, 1985-2013. MMWR Morb Mortal Wkly Rep. 2015, 63:1245-6.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1915826","article-title":"HIV infection - screening, diagnosis, and treatment","volume":"384","author":"Saag MS","year":"2021","unstructured":"Saag MS. HIV infection - screening, diagnosis, and treatment. N Engl J Med. 2021, 384:2131-43. 10.1056\/NEJMcp1915826","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agaa085","article-title":"Second hits exacerbate alcohol-related organ damage: an update","volume":"56","author":"Osna NA","year":"2021","unstructured":"Osna NA, Ganesan M, Seth D, Wyatt TA, Kidambi S, Kharbanda KK. Second hits exacerbate alcohol-related organ damage: an update. Alcohol Alcohol. 2021, 56:8-16. 10.1093\/alcalc\/agaa085","journal-title":"Alcohol Alcohol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000777","article-title":"HIV and chronic lung disease","volume":"18","author":"Leung JM","year":"2023","unstructured":"Leung JM. HIV and chronic lung disease. Curr Opin HIV AIDS. 2023, 18:93-101. 10.1097\/COH.0000000000000777","journal-title":"Curr Opin HIV AIDS"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2022.2080801","article-title":"Association of syndemic conditions and quality of life among people living with HIV\/AIDS","volume":"35","author":"de Oliveira Gomes M","year":"2023","unstructured":"de Oliveira Gomes M, Castro R, Corr\u00eaa da Mota J, De Boni RB. Association of syndemic conditions and quality of life among people living with HIV\/AIDS. AIDS Care. 2023, 35:1508-17. 10.1080\/09540121.2022.2080801","journal-title":"AIDS Care"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-020-00945-0","article-title":"Vasculitides in HIV Infection","volume":"22","author":"Vega LE","year":"2020","unstructured":"Vega LE, Espinoza LR. Vasculitides in HIV Infection. Curr Rheumatol Rep. 2020, 22:60. 10.1007\/s11926-020-00945-0","journal-title":"Curr Rheumatol Rep"},{"key":"ref45","unstructured":"Exposure to Blood. (2003). Accessed. December 10th, 2023: https:\/\/www.cdc.gov\/hai\/pdfs\/bbp\/exp_to_blood.pdf."},{"key":"ref46","article-title":"Needle stick injuries in the community","volume":"13","year":"2008","unstructured":"Needle stick injuries in the community. Paediatr Child Health. 2008, 13.205-10.","journal-title":"Paediatr Child Health"},{"key":"ref47","unstructured":"HIV Needle Stick Risk Assessment Stratification Protocol (RASP). Accessed. December 10, 2023: https:\/\/www.mdcalc.com\/calc\/780\/hiv-needle-stick-risk-assessment-stratification-protocol-rasp."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/213341-incidence-and-risks-of-hiv-infection-medication-options-and-adverse-effects-in-accidental-needle-stick-injuries-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:13:19Z","timestamp":1707509599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/213341-incidence-and-risks-of-hiv-infection-medication-options-and-adverse-effects-in-accidental-needle-stick-injuries-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":47,"URL":"https:\/\/doi.org\/10.7759\/cureus.51521","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,2]]}}}